UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 105

Sortiert nach

Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy

Molecular cancer, 2021-01, Vol.20 (1), p.2-20, Article 2

2021

Volltextzugriff (PDF)

Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model

Molecular cancer therapeutics, 2017-02, Vol.16 (2), p.312-322

2017

Volltextzugriff (PDF)

Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment

International journal of molecular sciences, 2021-04, Vol.22 (9), p.4584

2021

Volltextzugriff (PDF)

Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy

Signal transduction and targeted therapy, 2021-01, Vol.6 (1), p.12-12, Article 12

2021

Volltextzugriff (PDF)

Sorafenib and 2-Deoxyglucose Synergistically Inhibit Proliferation of Both Sorafenib-Sensitive and -Resistant HCC Cells by Inhibiting ATP Production

Gene expression, 2017-02, Vol.17 (2), p.129-140

2017

Volltextzugriff (PDF)

Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma

Cancers, 2020-09, Vol.12 (10), p.2730

2020

Volltextzugriff (PDF)

Tumor microenvironment promotes breast cancer chemoresistance

Cancer chemotherapy and pharmacology, 2021-02, Vol.87 (2), p.147-158

2021

Volltextzugriff (PDF)

Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway

Molecular carcinogenesis, 2016-12, Vol.55 (12), p.2063-2076

2016

Volltextzugriff (PDF)

Correction: Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy

Signal transduction and targeted therapy, 2021-02, Vol.6 (1), p.93-93, Article 93

2021

Volltextzugriff (PDF)

Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer

Molecular oncology, 2015-04, Vol.9 (4), p.906-919

2015

Volltextzugriff (PDF)

miRNAs as novel immunoregulators in cancer

Seminars in cell & developmental biology, 2022-04, Vol.124, p.3-14

2022

Volltextzugriff (PDF)

Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the Stroma

Molecular cancer therapeutics, 2020-02, Vol.19 (2), p.384-396

2020

Volltextzugriff (PDF)

Immuno-Oncology Crosstalk and Metabolism

1, 2022

Volltextzugriff (PDF)

Recent Advances in Head and Neck Tumor Microenvironment–Based Therapy

Tumor Microenvironments in Organs, 2020, Vol.1296, p.11-31

2020

Volltextzugriff (PDF)

Abstract 1166: CXCR7-mediated signaling axis regulates breast cancer growth and metastasis by modulating tumor microenvironment

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1166-1166

Wani, Nissar A.

2014

Volltextzugriff (PDF)

Su2005 Downregulation of Folate Transporters in Membrane Lipid Rafts Contributes to Decreased Hepatic Folate Uptake in Ethanol Fed Rats

Gastroenterology (New York, N.Y. 1943), 2012-05, Vol.142 (5), p.S-558-S-558

2012

Volltextzugriff (PDF)

C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment

Breast cancer research : BCR, 2014-05, Vol.16 (3), p.R54-R54, Article R54

2014

Volltextzugriff (PDF)

Abstract 2521: Inhibition of metabolic reprogramming by zerumbone alters the tumorigenic potential of hepatocellular cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.2521-2521

2017

Volltextzugriff (PDF)

Abstract 3470: Ibrutinib and sorafenib synergistically inhibit HCC growth in preclinical models

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3470-3470

2018

Volltextzugriff (PDF)

Ibrutinib potentiates anti-hepatocarcinogenic efficacy of sorafenib by targeting EGFR in tumor cells and BTK in immune cells in the stroma

Molecular cancer therapeutics, 2019-10, Vol.19 (2), p.384-396

2019

Volltextzugriff (PDF)

Abstract 3363: RAGE/S100A7/Stat3-axis enhances breast cancer growth and metastasis via modulating tumor microenvironment

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3363-3363

2015

Volltextzugriff (PDF)

Immuno-onco-metabolism and Therapeutic Resistance

Immuno-Oncology Crosstalk and Metabolism, 2022, p.45-89

2022

Volltextzugriff (PDF)

Immune Cell Metabolites as Fuel for Cancer Cells

Immuno-Oncology Crosstalk and Metabolism, 2022, p.153-186

2022

Volltextzugriff (PDF)

Immune Cell Metabolism and Function

Immuno-Oncology Crosstalk and Metabolism, 2022, p.1-20

2022

Volltextzugriff (PDF)

Timing of the Major Metabolic Switches in Immune Cell Activation and Differentiation During Cancer Development

Immuno-Oncology Crosstalk and Metabolism, 2022, p.187-218

2022

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Englisch
(104)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy

Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an Effective Therapy for Hepatocellular Cancer in a Mouse Model

Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment

Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy

Sorafenib and 2-Deoxyglucose Synergistically Inhibit Proliferation of Both Sorafenib-Sensitive and -Resistant HCC Cells by Inhibiting ATP Production

Transcriptomics-Based Drug Repurposing Approach Identifies Novel Drugs against Sorafenib-Resistant Hepatocellular Carcinoma

Tumor microenvironment promotes breast cancer chemoresistance

Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway

Correction: Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy

Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti-tumor mechanisms of Cannabidiol in breast cancer

miRNAs as novel immunoregulators in cancer

Ibrutinib Potentiates Antihepatocarcinogenic Efficacy of Sorafenib by Targeting EGFR in Tumor Cells and BTK in Immune Cells in the Stroma

Immuno-Oncology Crosstalk and Metabolism

Recent Advances in Head and Neck Tumor Microenvironment–Based Therapy

Abstract 1166: CXCR7-mediated signaling axis regulates breast cancer growth and metastasis by modulating tumor microenvironment

Su2005 Downregulation of Folate Transporters in Membrane Lipid Rafts Contributes to Decreased Hepatic Folate Uptake in Ethanol Fed Rats

C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment

Abstract 2521: Inhibition of metabolic reprogramming by zerumbone alters the tumorigenic potential of hepatocellular cancer

Abstract 3470: Ibrutinib and sorafenib synergistically inhibit HCC growth in preclinical models

Ibrutinib potentiates anti-hepatocarcinogenic efficacy of sorafenib by targeting EGFR in tumor cells and BTK in immune cells in the stroma

Abstract 3363: RAGE/S100A7/Stat3-axis enhances breast cancer growth and metastasis via modulating tumor microenvironment

Immuno-onco-metabolism and Therapeutic Resistance

Immune Cell Metabolites as Fuel for Cancer Cells

Immune Cell Metabolism and Function

Timing of the Major Metabolic Switches in Immune Cell Activation and Differentiation During Cancer Development

Suchergebnisse filtern